2021
Havana
TITM
Plant for the production and commercialization of products derived from the human placenta
Construction of a plant for the production and commercialization of products derived from the human placenta for the treatment of diseases such as vitiligo, psoriasis and alopecia areata, as well as the production of cosmetics with therapeutic action for facial, body and hair lines, in addition to nutritional supplements destined mainly for export.